Currently, this follow-up cohort of one hundred fifty-nine 9-year-old offspring whose mothers received either metformin or insulin treatment of GDM is the largest published cohort comparing long-term effects of the medication on the cognitive and neuropsychological profiles of offspring. The gene discussed is INS; the disease is gestational diabetes.